Digital Health Series B Investors & VC Firms
450 firms in this list, with a median first check of $1M. 142 of them lead rounds. Generated from verified public data and updated continuously.
Epsilon Health Investors
WashingtonSeed–Series B
20 people
Hi Inov
ParisSeed–Series B$1.1M – $16.5M
19 people
Tal Ventures
Tel AvivPre-Seed–Late Stage
8 people
Lifeforce Capital
Chevy ChaseSeed–Series C$500K – $5M
4 people
Hadean Ventures
OsloSeed–Growth
21 people
Informed Ventures Advisors, Llc
Menlo ParkSeed–Late Stage
9 people
SpringTide Ventures
BostonSeed–Series B$500K – $5M
15 people
Qiming Venture Partners USA
CambridgeSeed–Series B
19 people
Unorthodox Ventures
AustinSeed–Growth$1M – $5M
16 people
New York Life Ventures
New YorkSeed–Growth
14 people
MDI Ventures
JakartaPre-Seed–Growth
12 people
JobsOhio Ventures
ColumbusSeed–Series B
4 people
Sonder Capital
San CarlosPre-Seed–Series C
17 people
Neva Sgr.
TurinSeries A–Growth
8 people
Medical Excellence Capital
New YorkSeed–Series B
19 people
Alpha Square Group
New YorkSeries A–Series B
14 people
BRM Capital
Tel AvivSeed–Growth
14 people
Wormhole Capital
Pre-Seed–Growth
2 people
Black Opal Ventures
New YorkSeed–Late Stage
18 people
Quan Capital
ShanghaiSeed–Growth
17 people
New Alliance Capital
ShanghaiSeed–Late Stage
25 people
Crew Capital
New YorkPre-Seed–Growth$500K – $2M
5 people
PACE Healthcare Capital
ChicagoSeed–Series B$1M – $4M
18 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$2M – $10M
10 people
Related lists
Series B Investors & VC Firms (2954)Series B Investors & VC Firms in North America (1744)Series B Investors & VC Firms in United States (1578)Digital Health Investors & VC Firms (1568)Digital Health Seed Investors & VC Firms (1261)Digital Health Investors & VC Firms in North America (1143)Series B Investors & VC Firms in Europe (1078)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Global (1068)Digital Health Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.































































































